135 related articles for article (PubMed ID: 23227280)
1. Orthotopic heart transplant facilitated autologous hematopoietic stem cell transplantation in light-chain amyloidosis.
Kamble RT
Methodist Debakey Cardiovasc J; 2012; 8(3):17-8. PubMed ID: 23227280
[TBL] [Abstract][Full Text] [Related]
2. Regression of Cardiac Amyloidosis Following Autologous Stem Cell Transplant in Patients With Atypical Magnetic Resonance Imaging Findings.
Enriquez-Rodriguez LE; Stone J; Mor-Avi V; Lang RM; Patel AR
Rev Esp Cardiol (Engl Ed); 2019 Sep; 72(9):790-792. PubMed ID: 30598381
[No Abstract] [Full Text] [Related]
3. Heart transplantation in systemic (AL) amyloidosis: a retrospective study of eight French patients.
Mignot A; Varnous S; Redonnet M; Jaccard A; Epailly E; Vermes E; Boissonnat P; Gandjbakhch I; Herpin D; Touchard G; Bridoux F
Arch Cardiovasc Dis; 2008 Sep; 101(9):523-32. PubMed ID: 19041836
[TBL] [Abstract][Full Text] [Related]
4. Autologous stem cell transplant after heart transplant for light chain (Al) amyloid cardiomyopathy.
Lacy MQ; Dispenzieri A; Hayman SR; Kumar S; Kyle RA; Rajkumar SV; Edwards BS; Rodeheffer RJ; Frantz RP; Kushwaha SS; Clavell AL; Dearani JA; Sundt TM; Daly RC; McGregor CG; Gastineau DA; Litzow MR; Gertz MA
J Heart Lung Transplant; 2008 Aug; 27(8):823-9. PubMed ID: 18656793
[TBL] [Abstract][Full Text] [Related]
5. Cardiac transplantation followed by dose-intensive melphalan and autologous stem-cell transplantation for light chain amyloidosis and heart failure.
Dey BR; Chung SS; Spitzer TR; Zheng H; Macgillivray TE; Seldin DC; McAfee S; Ballen K; Attar E; Wang T; Shin J; Newton-Cheh C; Moore S; Sanchorawala V; Skinner M; Madsen JC; Semigran MJ
Transplantation; 2010 Oct; 90(8):905-11. PubMed ID: 20733534
[TBL] [Abstract][Full Text] [Related]
6. Delayed autologous stem cell transplantation following cardiac transplantation experience in patients with cardiac amyloidosis.
Trachtenberg BH; Kamble RT; Rice L; Araujo-Gutierrez R; Bhimaraj A; Guha A; Park MH; Hussain I; Bruckner BA; Suarez EE; Victor DW; Adrogue HE; Baker KR; Estep JD
Am J Transplant; 2019 Oct; 19(10):2900-2909. PubMed ID: 31152491
[TBL] [Abstract][Full Text] [Related]
7. Prognostic and Added Value of Two-Dimensional Global Longitudinal Strain for Prediction of Survival in Patients with Light Chain Amyloidosis Undergoing Autologous Hematopoietic Cell Transplantation.
Pun SC; Landau HJ; Riedel ER; Jordan J; Yu AF; Hassoun H; Chen CL; Steingart RM; Liu JE
J Am Soc Echocardiogr; 2018 Jan; 31(1):64-70. PubMed ID: 29111123
[TBL] [Abstract][Full Text] [Related]
8. Plerixafor-augmented peripheral blood stem cell mobilization in AL amyloidosis with cardiac involvement: a case series.
Lee SY; Sanchorawala V; Seldin DC; Mark Sloan J; Andrea N; Quillen K
Amyloid; 2014 Sep; 21(3):149-53. PubMed ID: 24779777
[TBL] [Abstract][Full Text] [Related]
9. Outcome of patients with systemic light chain amyloidosis with concurrent renal and cardiac involvement.
Badar T; Cornelison AM; Shah ND; Bashir Q; Parmar S; Patel K; Hosing C; Popat U; Weber DM; Thomas SK; Shah JJ; Orlowski RZ; Champlin RE; Qazilbash MH
Eur J Haematol; 2016 Oct; 97(4):342-7. PubMed ID: 26773409
[TBL] [Abstract][Full Text] [Related]
10. [Heart transplantation and follow-up treatment with AL-amyloidosis in 5 patients].
Adam Z; Ozábalová E; Němec P; Bedáňová H; Kuman M; Krejčí J; Špinarová L; Žampachová V; Čermáková Z; Pour L; Krejčí M; Sanecká V; Štork M; Pika T; Straub J; Adamová D; Stavařová Y; Král Z; Mayer J
Vnitr Lek; 2018; 64(4):441-449. PubMed ID: 29791180
[TBL] [Abstract][Full Text] [Related]
11. Predictors of survival to orthotopic heart transplant in patients with light chain amyloidosis.
Gray Gilstrap L; Niehaus E; Malhotra R; Ton VK; Watts J; Seldin DC; Madsen JC; Semigran MJ
J Heart Lung Transplant; 2014 Feb; 33(2):149-56. PubMed ID: 24200511
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of Patients with Light Chain Amyloidosis Who Had Autologous Stem Cell Transplantation with 3 or More Organs Involved.
Al Saleh AS; Sidiqi MH; Muchtar E; Dispenzieri A; Buadi FK; Dingli D; Lacy MQ; Warsame RM; Gonsalves WI; Kourelis TV; Hogan WJ; Hayman SR; Kapoor P; Kumar SK; Gertz MA
Biol Blood Marrow Transplant; 2019 Aug; 25(8):1520-1525. PubMed ID: 31054986
[TBL] [Abstract][Full Text] [Related]
13. Heart transplantation and end-stage cardiac amyloidosis: a review and approach to evaluation and management.
Estep JD; Bhimaraj A; Cordero-Reyes AM; Bruckner B; Loebe M; Torre-Amione G
Methodist Debakey Cardiovasc J; 2012; 8(3):8-16. PubMed ID: 23227279
[TBL] [Abstract][Full Text] [Related]
14. Managing cardiac amyloidosis: auto or allotransplant?
Badari A; Brown K; Paplham P; Syta M; Burgess M; Arnold K; Liu J; Chen G; Liu H; Ross M; Hahn T; McCarthy P
Am J Hematol; 2011 Oct; 86(10):885-6. PubMed ID: 21922529
[No Abstract] [Full Text] [Related]
15. Autologous stem-cell transplantation in progressing amyloidosis is associated with severe transplant-related toxicity.
Worel N; Schulenburg A; Mitterbauer M; Keil F; Rabitsch W; Kalhs P; Gisslinger H; Raderer M; Geissler K; Höcker P; Zielinski CC; Oberbauer R; Greinix HT
Wien Klin Wochenschr; 2006 Feb; 118(1-2):49-53. PubMed ID: 16489526
[TBL] [Abstract][Full Text] [Related]
16. Sequential heart and autologous stem cell transplantation for systemic AL amyloidosis.
Gillmore JD; Goodman HJ; Lachmann HJ; Offer M; Wechalekar AD; Joshi J; Pepys MB; Hawkins PN
Blood; 2006 Feb; 107(3):1227-9. PubMed ID: 16210334
[TBL] [Abstract][Full Text] [Related]
17. Emerging therapy in light-chain and acquired transthyretin-related amyloidosis: an Italian single-centre experience in heart transplantation.
Di Nora C; Sponga S; Ferrara V; Patriarca F; Fanin R; Nalli C; Lechiancole A; Vendramin I; Livi U
J Cardiovasc Med (Hagerstown); 2021 Apr; 22(4):261-267. PubMed ID: 33633041
[TBL] [Abstract][Full Text] [Related]
18. Autologous Stem Cell Transplantation in Patients With Primary Systemic Amyloidosis: Experience of a Tertiary Hospital.
Domínguez-Muñoz MA; Calderón-Cabrera C; Martino-Galiana ML; Martín-Sánchez J
Transplant Proc; 2015 Nov; 47(9):2661-4. PubMed ID: 26680066
[TBL] [Abstract][Full Text] [Related]
19. Progressive renal light chain amyloidosis with the absence of detectable free monoclonal light chains after an autologous hematopoietic stem cell transplant for amyloid light chain amyloidosis.
Roth RM; Benson D; Hebert LA; Bissell MG; Satoskar AA; Nadasdy T; Brodsky SV
Arch Pathol Lab Med; 2013 Sep; 137(9):1304-8. PubMed ID: 23991744
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of heart transplantation in cardiac amyloidosis: an updated systematic review.
Lakhdar S; Buttar C; Nassar M; Ciobanu C; Patel R; Munira MS
Heart Fail Rev; 2022 Nov; 27(6):2201-2209. PubMed ID: 35595919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]